U10 DA013720/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	1
2003	1
2004	3
2005	2
2006	2
2007	5
2008	4
2009	8
2010	11
2011	12
2012	11
2013	17
2014	15
2015	13
2016	10
2017	9
2018	11
2019	12
2020	7
2021	9
2022	4
2023	1
2024	0

1

Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics.

Ruglass LM, Shevorykin A, Zhao Y, Killeen TK, Bauer AG, Morgan-López AA, Back SE, Fitzpatrick S, López-Castro T, Norman SB, Saavedra LM, Hien DA. Ruglass LM, et al. Drug Alcohol Depend. 2023 Mar 1;244:109769. doi: 10.1016/j.drugalcdep.2023.109769. Epub 2023 Jan 14. Drug Alcohol Depend. 2023. PMID: 36696843 Free PMC article. Clinical Trial.

2

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment.

Pan Y, Feaster DJ, Odom G, Brandt L, Hu MC, Weiss RD, Rotrosen J, Saxon AJ, Luo SX, Balise RR. Pan Y, et al. Drug Alcohol Depend Rep. 2022 Dec;5:100128. doi: 10.1016/j.dadr.2022.100128. Epub 2022 Dec 5. Drug Alcohol Depend Rep. 2022. PMID: 36644227 Free PMC article.

3

Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes.

Bunting AM, Krawczyk N, Choo TH, Pavlicova M, McNeely J, Tofighi B, Rotrosen J, Nunes E, Lee JD. Bunting AM, et al. J Subst Abuse Treat. 2022 Dec;143:108830. doi: 10.1016/j.jsat.2022.108830. Epub 2022 Jun 22. J Subst Abuse Treat. 2022. PMID: 35773113 Free PMC article. Clinical Trial.

4

Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection Naltrexone.

Na PJ, Scodes J, Fishman M, Rotrosen J, Nunes EV. Na PJ, et al. J Clin Psychiatry. 2022 Apr 18;83(3):21m14140. doi: 10.4088/JCP.21m14140. J Clin Psychiatry. 2022. PMID: 35452194 Clinical Trial.

5

Predictors of therapeutic alliance, treatment feedback, and clinical outcomes among African American women in treatment for co-occurring PTSD and SUD.

Bauer AG, Ruglass LM, Shevorykin A, Saraiya TC, Robinson G, Cadet K, Julien L, Chao T, Hien D. Bauer AG, et al. J Subst Abuse Treat. 2022 Aug;139:108766. doi: 10.1016/j.jsat.2022.108766. Epub 2022 Mar 22. J Subst Abuse Treat. 2022. PMID: 35346534 Free PMC article. Clinical Trial.

6

Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial.

Roache JD, Pavlicova M, Campbell A, Choo TH, Peavy M, Kermack AS, Nunes EV Jr, Rotrosen J. Roache JD, et al. Alcohol Clin Exp Res. 2021 Dec;45(12):2569-2578. doi: 10.1111/acer.14729. Epub 2021 Nov 23. Alcohol Clin Exp Res. 2021. PMID: 34698397 Free PMC article.

7

Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.

Nunes EV Jr, Scodes JM, Pavlicova M, Lee JD, Novo P, Campbell ANC, Rotrosen J. Nunes EV Jr, et al. Am J Psychiatry. 2021 Jul;178(7):660-671. doi: 10.1176/appi.ajp.2020.20060816. Epub 2021 Jun 25. Am J Psychiatry. 2021. PMID: 34170188 Free PMC article. Clinical Trial.

8

Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.

Fishman M, Wenzel K, Scodes J, Pavlicova M, Campbell ANC, Rotrosen J, Nunes E. Fishman M, et al. Am J Addict. 2021 Sep;30(5):433-444. doi: 10.1111/ajad.13176. Epub 2021 Jun 1. Am J Addict. 2021. PMID: 34075644 Free PMC article. Clinical Trial.

9

Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis.

Murphy SM, Jeng PJ, McCollister KE, Leff JA, Jalali A, Shulman M, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR. Murphy SM, et al. Addiction. 2021 Dec;116(12):3444-3453. doi: 10.1111/add.15531. Epub 2021 May 21. Addiction. 2021. PMID: 33950535 Free PMC article. Clinical Trial.

10

Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use.

Traynor SM, Metsch LR, Gooden L, Stitzer M, Matheson T, Tross S, Carrico AW, Jain MK, Del Rio C, Feaster DJ. Traynor SM, et al. Drug Alcohol Depend. 2021 Apr 1;221:108567. doi: 10.1016/j.drugalcdep.2021.108567. Epub 2021 Feb 3. Drug Alcohol Depend. 2021. PMID: 33610093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

136 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year